Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases.

Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases.
Shuttleworth S, Townsend P, Silva F, Cecil A, Hill T, Tomassi C, Rogers H, Harrison R.
Prog Med Chem. 2011, 50, p109-33.